| |
| |
|
| Insider
Information: |
Metzger Michael A |
| Relationship: |
|
| City: |
Los Angeles |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
164,909 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,583,051 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
164,909 |
|
|
| Total
Value |
$3,583,051 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Response Genetics Inc |
RGDX |
Director |
2012-02-02 |
1,000 |
2012-02-02 |
0 |
Premium* |
|
|
Cti Biopharma Corporation |
CTIC |
Director |
2022-11-08 |
0 |
2018-01-20 |
0 |
Premium* |
|
|
Syndax Pharmaceuticals Inc |
SNDX |
|
2024-02-07 |
163,909 |
2019-01-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
146,250 |
163,909 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
AS |
$27.64 |
$164,697 |
D/D |
(5,959) |
17,659 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
OE |
$6.38 |
$38,018 |
D/D |
5,959 |
23,618 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2022-11-08 |
4 |
AS |
$5.53 |
$511,019 |
D/D |
(91,500) |
0 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2022-11-08 |
4 |
OE |
$0.84 |
$86,971 |
D/D |
91,500 |
91,500 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-10-06 |
4 |
AS |
$25.29 |
$410,508 |
D/D |
(16,231) |
17,659 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-10-06 |
4 |
OE |
$8.77 |
$142,346 |
D/D |
16,231 |
33,890 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-10-04 |
4 |
OE |
$8.77 |
$11,226 |
D/D |
1,280 |
18,939 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-10-04 |
4 |
AS |
$25.02 |
$32,026 |
D/D |
(1,280) |
17,659 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-10-03 |
4 |
AS |
$25.01 |
$72,107 |
D/D |
(2,883) |
17,659 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-10-03 |
4 |
OE |
$8.77 |
$25,284 |
D/D |
2,883 |
20,542 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-09-30 |
4 |
AS |
$25.02 |
$740,757 |
D/D |
(29,606) |
17,659 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-09-30 |
4 |
OE |
$8.77 |
$259,645 |
D/D |
29,606 |
47,265 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-07-25 |
4 |
OE |
$6.38 |
$201,621 |
D/D |
31,602 |
29,497 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-07-25 |
4 |
AS |
$21.06 |
$665,393 |
D/D |
(31,602) |
17,659 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2022-07-07 |
4 |
AS |
$6.50 |
$130,995 |
D/D |
(20,121) |
0 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-07-07 |
4 |
AS |
$21.00 |
$2,100 |
D/D |
(100) |
17,659 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-07-07 |
4 |
OE |
$6.38 |
$638 |
D/D |
100 |
17,759 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-07-06 |
4 |
AS |
$21.07 |
$316,307 |
D/D |
(15,009) |
17,659 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-07-06 |
4 |
OE |
$6.38 |
$95,757 |
D/D |
15,009 |
32,668 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2022-07-05 |
4 |
AS |
$5.98 |
$556,067 |
D/D |
(91,500) |
20,121 |
0 |
% |
|
| CTIC |
Cti Biopharma Corporation |
Director |
– • – |
2022-07-05 |
4 |
OE |
$0.84 |
$76,961 |
D/D |
91,500 |
111,621 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
President and COO |
• • – |
2021-12-20 |
4 |
AS |
$20.29 |
$1,237,568 |
D/D |
(61,000) |
17,659 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
President and COO |
• • – |
2021-12-20 |
4 |
OE |
$6.38 |
$496,730 |
D/D |
61,000 |
62,659 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
President and COO |
• • – |
2021-12-17 |
4 |
AS |
$19.02 |
$31,877 |
D/D |
(1,676) |
17,659 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
